Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Pharma News, Views & Analysis
Filter
News
Articles
Podcasts
Infographics
Advertise With Us
Advertise With Us
What should marketing and medical affairs invest in for Q4?
Join Jade and Isabel as they explore the critical trends that have shaped the industry in 2024 and what teams should leverage in Q4.
Read more
Changing the tide on health inequities
Listen to Marion Brooks, Vice President and US Country Head, Diversity, Equality and Inclusion, Novartis discussing diversity, equity and inclusion.
Why HCPs are losing trust in pharma marketing
Discover why healthcare professionals are losing trust in pharma marketing. Listen the episode as the GOLD team delves into the industry’s challenges.
Time to trade in the traditional marketing model?
The evolution of customer engagement in pharmaceutical industry according to Rick Hollis, Director of Business Excellence, Ipsen. Listen now!
Meet GOLD's latest catalyst - ImmunoGen’s Dr Andreas Konieczny
In this episode of GOLD podcast, the latest catalyst ImmunoGen’s Andreas Konieczny offers insights on driving drug launches and leadership skills. Listen now!
Investigating the reality of rare disease research
Discover the reality behind the rare disease research with Dr Ian Winburn, Vice President, Global Lead for Rare Hematology, Pfizer
Do happy employees equal better innovation?
In this episode, Nate Cope, Chief Operating Officer, Otsuka Europe, details how companies can drive innovation by being a great place to work.
Taking the pulse of digital health
Parveen Jayia, Therapy Area Head, Breast and Gynaecological Cancers, AstraZeneca, talks to GOLD about the role digital health can play in the future of the industry.
Season finale: Going the extra mile for patients with disabilities
Join Jade as she sits down with Christy Seigel, General Manager, Breast and Women’s Cancers Portfolio, Novartis US Oncology, to discuss the importance of disability inclusion in the pharmaceutical industry.
Loading posts...
« Previous
1
2
3
4
5
6
…
23
Next »